Skip to main content
SpringerPlus

Table 2 Treatments for stage III and stage IV patients

From: A prospective evaluation of the role of Vascular Endothelial Growth Factor (VEGF) and the immune system in stage III/IV melanoma

Stage III (n = 10)

  
 

Treatments

# patients

 

None

3

 

Immunotherapy

7

Stage IV (n = 22)

  
 

Treatments

# patients

 

Immunotherapy

11

 

Chemo

2

 

Immunotherapy, Chemo

3

 

Immunotherapy, Chemo, Anti-angiogenic

3

 

Vaccine, Immunotherapy

1

 

Immunotherapy, Chemo, Anti-angiogenic, Targeted

2

  1. Chemo – chemotherapy, Targeted – targeted therapy, Immunotherapies include: High-dose Interleukin-2, Ipilimumab, granulocyte macrophage colony-stimulating factor, and interferon; Chemotherapies include: carboplatin, paclitaxel, paclitaxel nanoparticle albumin-bound, and temozolomide; Targeted therapies include: vemurafenib; Anti-angiogenic agents include: thalidomide, bevacizumab.
Back to article page